Order Article Reprints

Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, et al. SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study. Vaccines. 2022; 10(8):1290. https://doi.org/10.3390/vaccines10081290

Vakhrusheva, Anna V., Aleksandr V. Kudriavtsev, Nickolay A. Kryuchkov, Roman V. Deev, Maria E. Frolova, Konstantin A. Blagodatskikh, Milana Djonovic, Andrey A. Nedorubov, Elena Odintsova, Aleksandr V. Ivanov, and et al. 2022. "SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study" Vaccines 10, no. 8: 1290. https://doi.org/10.3390/vaccines10081290

Vakhrusheva, A. V., Kudriavtsev, A. V., Kryuchkov, N. A., Deev, R. V., Frolova, M. E., Blagodatskikh, K. A., Djonovic, M., Nedorubov, A. A., Odintsova, E., Ivanov, A. V., Romanovskaya-Romanko, E. A., Stukova, M. A., Isaev, A. A., & Krasilnikov, I. V. (2022). SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study. Vaccines, 10(8), 1290. https://doi.org/10.3390/vaccines10081290